COVID-19大流行对精神药物使用的影响:全人群队列的时间序列分析
2020年3月所有药物使用超出预期, antidepressant、抗焦虑药和抗精神病药从5月回归预期趋势。限制期8个月内,18岁以下催眠药使用比预期高12%,65岁以上抗焦虑药高于预期。
要点
- 2020年3月所有精神药物使用超出预期,提示初始囤药行为。
- 抗抑郁药、抗焦虑药和抗精神病药从2020年5月回归预期趋势。
- 限制期8个月内,18岁以下催眠药使用比预期高12%,65岁以上抗焦虑药高于预期。
核心结论
- 结果提示2020年3月出现初始囤药,随后趋势大多回归预期水平。
- 预期的精神疾病浪潮尚未在精神药物使用中显现。
- 部分亚组有焦虑和睡眠困难增加的迹象,但可能无需精神科干预即可随疫情缓解而消退。
研究设计与样本
- 在R中训练自回归整合移动平均(ARIMA)模型,考虑趋势和季节效应。
- 将预测(期望)月度值与实际值比较,并按人口学因素分层。
主要发现
- 研究期间38.5%的研究人群接受过至少1种精神药物。
- 自2012年1月以来精神药物使用呈强劲上升趋势。
- 2020年3月所有药物使用超出预期值,抗抑郁药、抗焦虑药和抗精神病药从2020年5月回归预期趋势。
- 限制期8个月内,18岁以下人群催眠药使用比预期高12%,65岁以上人群抗焦虑药使用高于预期。
临床怎么用
- 结果提示疫情初期可能出现囤药行为,后续处方趋势大多回归预期。
- 部分亚组(18岁以下、65岁以上)有焦虑和睡眠困难增加的迹象。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The COVID-19 pandemic and associated lockdowns were predicted to have a major impact on mental health, however current studies have produced contradictory findings with limited longitudinal data. AIMS: Nine years of linked, individual-level administrative data were used to examine changes in psychotropic medication uptake before and during the pandemic. METHOD: Medication data from a population-wide prescribing database were linked to demographic and socioeconomic indicators from healthcare registration records (n = 1 801 860). Monthly prescription uptake was split (pre-restrictions: January 2012 to February 2020 and during restrictions: March to October 2020). Auto regressive integrated moving average (ARIMA) models were trained in R taking into consideration trends and seasonal effects. Forecast ('expected') monthly values were compared with 'actual' values, stratified by demographic factors. RESULTS: Over the study period 38.5% of the study population were in receipt of ≥1 psychotropic medication. Uptake of these medications have been following a strong upward trend since January 2012. In March 2020 uptake of all medications increased beyond expected values, returning to expected trends from May 2020 for antidepressants, anxiolytics and antipsychotics. In the 8 months during restrictions uptake of hypnotic medication was 12% higher than expected among those <18 years, and anxiolytic medication higher than expected in those >65 years. CONCLUSIONS: Results suggest an initial 'stockpiling' of medications in March 2020 before trends mostly returned to expected levels. The anticipated tsunami of mental ill health is not yet manifest in psychotropic medication uptake. There are indications of increased anxiety and sleep difficulties in some subgroups, although these conditions may resolve as we emerge from the pandemic without need for psychiatric intervention.
引用
- Maguire A, Kent L, O'Neill S, et al. Impact of the COVID-19 pandemic on psychotropic medication uptake: time-series analysis of a population-wide cohort. Br J Psychiatry. 2022. PMID: 35968915. doi:10.1192/bjp.2022.112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。